Achilles Therapeutics PLC 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
Achilles Therapeutics extends a manufacturing agreement with Cell and Gene Therapy Catapult and files its annual report on Form 20-F with the SEC.